News
Macquarie upgraded Atlassian (TEAM) to Outperform from Neutral with a price target of $270, down from $317.Stay Ahead of the Market: Discover ...
Novartis (NVS) announced a planned $23B investment over five years in U.S.-based infrastructure, ensuring all key Novartis medicines for U.S.
12h
TipRanks on MSNArgenica Completes Dosing in Phase 2 Stroke Trial for ARG-007Argenica Therapeutics Ltd ( ($AU:AGN) ) has issued an update. Argenica Therapeutics has completed dosing the last patient in its Phase 2 clinical ...
Renowned investor Cathie Wood, CEO of ARK Invest, encourages investors to look beyond the immediate market volatility stirred by President Trump’s tariff war. According to Barrons, Wood believes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results